If you’re a pet owner, odds are, you’re already giving your dog or cat the ultimate life of leisure. (I mean, same.)
And that’s why supplements are such a hot market, for humans and for pets. With promises of calm, relaxation, pain support, and more, it’s hard not to dabble and introduce something to your pet’s regimen that could make life easier or more pleasant.
So, what’s the deal? Is CBD all its cracked up to be? Does it even work?
The pet CBD market has grown to roughly $3 billion globally, and it’s sold in ordinary pet stores. It’s aimed largely at aging dogs who experience arthritis, anxiety, or seizures, and of course, at the owners who’ve watched a dog stop climbing the stairs or jumping on the bed with ease.
The research shows that pet CBD is more than nothing but it’s much less the packaging implies. Which to say, that’s also a familiar statement when it comes to supplement consumption and the human body.
The most-cited work is
with osteoarthritis, which found reduced pain and increased activity compared with placebo, with no observed side effects. Owners reported the tangible version: dogs jumping into cars again, climbing stairs, getting on the bed. pointed in the same direction. On the epilepsy side, a Colorado State crossover study in dogs with drug-resistant epilepsy reported a meaningful reduction in seizure frequency, with the effect tracking blood levels of CBD.But the caveats are substantial. These are small studies, in fact the Cornell trial ran sixteen dogs. That’s a rather small sample size. Many outcomes are owner-reported, which is exactly where placebo effect lives, since the owner is the one filling out the survey. Results across the arthritis literature are mixed rather than uniform.
Something else worth knowing is that the Cornell researcher most associated with this work also serves as chief medical officer of a pet CBD company. That doesn’t invalidate peer-reviewed findings, but you should know it, and most coverage of this research doesn’t mention it.
Now let’s close on two practical facts. Cannabinoids are metabolized more slowly in dogs and cats than in people, so effects last longer. And the FDA has approved no cannabinoid product for use in animals, meaning the quality-control situation is the same unregulated landscape as the human market with the same documented labeling problems.
If you’re going to try it
Talk to your vet first and know that roughly half of veterinarians in one survey didn’t feel comfortable discussing cannabinoids with clients. That’s changing, but if yours shuts the conversation down, it may reflect discomfort rather than evidence.
Buy from a brand that publishes batch-level third-party lab results and states a milligram dose. Confirm it’s made from certified hemp. And understand what you’re buying it for: the best evidence is in arthritis pain and drug-resistant epilepsy. Everything else on the label is ahead of the research.
For what it’s worth, the Cornell protocol used 2 mg per kilogram twice daily — that’s the study design, not a recommendation for your animal, and dosing is a conversation to have with your veterinarian rather than a number to take from a newsletter.
So treat your edibles like medication around your pets, tell your vet the truth if something happens, and treat the CBD chew aisle with the same skepticism you’d apply to any supplement sold without regulation.
Keep an animal poison control number where you can find it. The ASPCA Animal Poison Control Center and the Pet Poison Helpline both operate 24/7; both charge a consultation fee. This piece is informational and is not veterinary advice. If something has happened or you notice behavioral changes, call your vet.